EssilorLuxottica Société anonyme (EL.PA)
Analysts maintain a "buy" rating, anticipating a 21.9% upside driven by the company's market leadership and long-term growth prospects.
- Favorable long-term demographic and eye-care market trends.
- Strong analyst consensus with significant implied upside.
- Positive recent news flow and market attention.
- Healthy balance sheet and decent revenue growth.
- Neutral profitability and capital allocation scores.
- Elevated valuation multiples (PE).
- Overbought technical indicators and bearish SMA cross.
- Below-average trading volume.
- Evidence of customer dissatisfaction and market share loss.
- Exposure to competitive intensity from smaller brands.
- Potential for technical correction from overbought conditions.
- Share count up 1.1 % a year over 3 years
- Dividends took 33 % of earnings over 3 years
- Return on equity above 10 % in 0 of 5 years; no loss year
Summary. EssilorLuxottica, a global leader in ophthalmic lenses, frames, and sunglasses, operates within a growing eyewear market. The company benefits from secular tailwinds but faces competitive pressures and challenges in customer loyalty.
Earnings and Financials
EssilorLuxottica reported a revenue growth of 5.7% and earnings growth of 12.3%. Profit margins stand at 8.52% and gross margins at 60.03%, with a return on equity of 6.72%. The company maintains a healthy balance sheet with a debt-to-equity ratio of 38.36% and substantial cash reserves. Valuation metrics include a trailing P/E of 33.11x and a forward P/E of 22.30x.
Competition and Macro
The global eyewear market is projected to reach USD 211.20 billion by 2035, driven by urbanization and increasing access to eye care. EssilorLuxottica held over 13.0% market share in 2025, but faces competition, with reports indicating some market share loss to smaller brands. Strategic acquisitions and increased smart-glasses production capacity are underway.
Catalysts and Valuation
The stock's momentum is strong, with 19 out of 23 analysts recommending a "buy" and an average price target implying a 21.9% upside. However, technical indicators show the stock is overbought (RSI 84.77) with a bearish SMA cross, trading below its 200-day moving average. Recent trading volume is significantly below average, suggesting caution.